University Hospitals Case Medical Center has opened a new brain tumor vaccine trial and candidates are needed.
Researchers in the Neurological Institute and Ireland Cancer Center at University Hospitals Case Medical Center are in late-stage trials for an experimental vaccine for the treatment of glioblastoma (GBM), the most aggressive form of brain cancer.
So far, the vaccine has been used to treat about 70 patients nationally with virtually no side-effects. Currently 14 patients have enrolled at UH, the only site in Ohio to have opened the study and one of 20 national sites.
According to UH neurosurgeon Andrew Sloan, M.D., early results, although not published, seem encouraging. Half of the patients receiving the vaccine have survived for more than 30 months after treatment.
The vaccine is designed to teach the body's immune system to attack the tumor without attacking the normal brain cells. Another advantage of the vaccine compared to other experimental treatments is that there are few side-effects to vaccines.
For more information or to enroll in the study call 216 844 6054.
Source: Cleveland Health News, http://www.wkyc.com (accessed on Feb, 12, 2008)
Views:
1,936
Rating:
Comments
is the cytomegalovirus the cause of this?Im have hghs tittles from cmv...
Del.icio.us
Digg
Facebook
StumbleUpon